---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-037167"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T16:28:11.590081+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q3 revenue up 6.3% to $804M; net loss $454M on $512M goodwill impairment; cuts FY EBITDA guidance

## Summary
- Net revenue $804.0M (+6.3% YoY); net loss $454.1M vs prior year income $16.1M due to $511.9M goodwill impairment.
- Adjusted EBITDA $161.2M (+0.6% YoY); YTD cash from ops $325.4M, free cash flow $76.6M.
- FY23 guidance: revenue narrowed to $3.160–3.185B; EBITDA lowered to $630–650M (from $650–680M). Capex 10–12%; FCF 3–4% unchanged.
- Subsequent to quarter-end, repurchased $19.4M of common stock under share repurchase authorization.
- Management cites sleep product growth for record revenue; Humana contract delays weighed on EBITDA.

## SEC filing metadata
- accession: 0001628280-23-037167
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828023037167/0001628280-23-037167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828023037167/ahco-20231107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-037167
- JSON: https://secwatch.observer/filing/0001628280-23-037167.json
- Plain text: https://secwatch.observer/filing/0001628280-23-037167.txt

## Key facts
- Earnings Releases
  AdaptHealth Corp. reported third quarter ended September 30, 2023 results: revenue $804.0 million, net income Net loss attributable to AdaptHealth Corp. was $454.1 million. Guidance lowered.
  - Period: third quarter ended September 30, 2023
  - Revenue: $804.0 million
  - Net income: Net loss attributable to AdaptHealth Corp. was $454.1 million
  - Guidance: lowered
  - Result: reported results
  source text: quarter ended September 30, 2023. Third Quarter Results and Highlights All comparisons are to the quarter ended September 30, 2022 unless otherwise stated. • Net revenue was $804.0 million compared to $756.5 million, an increase of 6.3%. • Net loss attributable to AdaptHealth Corp. was $454.1 million compared to net income of $16.1 million, largely resulting from a
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725255/000162828023037167/0001628280-23-037167-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.